HB 195 – MontanaStatus: Inactive / Dead
Year Introduced: 2017
REVISE LAWS RELATED TO PHARMACIES AND PRESCRIPTION DRUGS: Allows pharmacists who receive a prescription for a specific drug product by brand or proprietary name may select a less expensive drug product with the same name, strength, quantity, dose and dosage form as the prescribed drug that is, in the pharmacist’s professional opinion, therapeutically equivalent, bio-equivalent and bio-available.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.